QCM
IONS icon

Qsemble Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Qsemble Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Sell
3,887
-21,871
-85% -$1.65M 0.04% 335
2026
Q1 		$1.93M Sell
25,758
-1,821
-7% -$144K 0.15% 194
2025
Q4 		$2.18M Buy
+27,579
New +$2.08M 0.18% 176
2025
Q1 		– Sell
-46,573
Closed -$1.63M – 506
2024
Q4 		$1.63M Buy
+46,573
New +$1.74M 0.22% 148

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Qsemble Capital Management's IONS Position: Q2 2026 in Review

Qsemble Capital Management reduced its Ionis Pharmaceuticals (IONS) stake by 85% in Q2 2026, selling an estimated $1.65M and leaving 3,887 shares worth $308K. The position accounts for 0.04% of the portfolio, ranked #335.

Qsemble Capital Management first reported a position in IONS in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.18M in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Qsemble Capital Management held 3,887 shares of Ionis Pharmaceuticals worth $308K as of Q2 2026.
  • Qsemble Capital Management sold 21,871 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.65M.
  • Ionis Pharmaceuticals made up 0.04% of Qsemble Capital Management's portfolio in Q2 2026, its #335 holding.
  • Qsemble Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Qsemble Capital Management's Ionis Pharmaceuticals position peaked at $2.18M in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.